Rekombinanter CA 19-9 Antikörper
Kurzübersicht für Rekombinanter CA 19-9 Antikörper (ABIN4949235)
Target
Alle CA 19-9 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Verwendungszweck
- Recombinant CA19-9 Antibody / Rabbit Monoclonal (azide and preservative free)
-
Aufreinigung
- Protein A affinity
-
Immunogen
- Purified human protein used as the immunogen for the recombinant CA19-9 antibody.
-
Isotyp
- IgG, kappa
-
-
-
-
Applikationshinweise
-
Optimal dilution of the recombinant CA19-9 antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the recombinant CA19-9 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
-
Andere Bezeichnung
- CA19-9
-
Hintergrund
- CA19-9, a carbohydrate epitope expressed on a high MW (>400 kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens.
Target
-